Literature DB >> 10782040

Cardiac opioids.

B A Barron1.   

Abstract

Opioid peptides have long been considered as neuropeptides or neurotransmitters. The more recent discovery of these same peptides in non-neuronal tissue suggests that the peptides may have autocrine, paracrine, or endocrine functions as well. The opioid peptides, enkephalins, dynorphins, and endorphins, have been found in isolated cardiac myocytes and heart tissue. This review will cover the recent literature on opioid peptides in respect to cardiac distribution, biochemistry, and function.

Mesh:

Substances:

Year:  2000        PMID: 10782040     DOI: 10.1046/j.1525-1373.2000.22358.x

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  10 in total

Review 1.  Reperfusion injury: does it exist?

Authors:  Garrett J Gross; John A Auchampach
Journal:  J Mol Cell Cardiol       Date:  2006-10-27       Impact factor: 5.000

Review 2.  Reducing safety-related drug attrition: the use of in vitro pharmacological profiling.

Authors:  Joanne Bowes; Andrew J Brown; Jacques Hamon; Wolfgang Jarolimek; Arun Sridhar; Gareth Waldron; Steven Whitebread
Journal:  Nat Rev Drug Discov       Date:  2012-12       Impact factor: 84.694

3.  Acute and chronic cardioprotection by the enkephalin analogue, Eribis peptide 94, is mediated via activation of nitric oxide synthase and adenosine triphosphate-regulated potassium channels.

Authors:  Garrett J Gross; Anna Hsu; Kasem Nithipatikom; Adam W Pfeiffer; Irina Bobrova; Erik Bissessar
Journal:  Pharmacology       Date:  2012-07-18       Impact factor: 2.547

4.  Microarray expression analysis in delayed cardioprotection: the effect of exercise, AICAR, or metformin and the possible role of AMP-activated protein kinase (AMPK).

Authors:  Lasse Solskov; Nils E Magnusson; Steen B Kristiansen; Niels Jessen; Torsten T Nielsen; Ole Schmitz; Hans Erik Bøtker; Sten Lund
Journal:  Mol Cell Biochem       Date:  2011-10-01       Impact factor: 3.396

Review 5.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  Evidence for MOR on cell membrane, sarcoplasmatic reticulum and mitochondria in left ventricular myocardium in rats.

Authors:  Sascha Treskatsch; Mohammed Shaqura; Lukas Dehe; Torsten K Roepke; Mehdi Shakibaei; Michael Schäfer; Shaaban A Mousa
Journal:  Heart Vessels       Date:  2015-12-19       Impact factor: 2.037

Review 7.  Therapeutic receptor targets of ischemic preconditioning.

Authors:  Ryan M Fryer; John A Auchampach; Garrett J Gross
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

8.  Hypertensive state, independent of hypertrophy, exhibits an attenuated decrease in systolic function on cardiac kappa-opioid receptor stimulation.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-30       Impact factor: 4.733

9.  Kappa and delta opioid receptor signaling is augmented in the failing heart.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2009-06-30       Impact factor: 5.000

10.  Prescription Opioid Use and Risk of Coronary Heart Disease, Stroke, and Cardiovascular Death Among Adults from a Prospective Cohort (REGARDS Study).

Authors:  Yulia Khodneva; Paul Muntner; Stefan Kertesz; Brett Kissela; Monika M Safford
Journal:  Pain Med       Date:  2016-02-08       Impact factor: 3.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.